Waters Corp
NYSE:WAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Waters Corp
EPS (Diluted)
Waters Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Waters Corp
NYSE:WAT
|
EPS (Diluted)
$10
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
EPS (Diluted)
$17
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
14%
|
|
|
Danaher Corp
NYSE:DHR
|
EPS (Diluted)
$5
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
EPS (Diluted)
$42
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
EPS (Diluted)
$4
|
CAGR 3-Years
1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
EPS (Diluted)
$7
|
CAGR 3-Years
11%
|
CAGR 5-Years
41%
|
CAGR 10-Years
10%
|
|
Waters Corp
Glance View
In the bustling world of life sciences, Waters Corp. stands as a pivotal player, charting its course at the intersection of science and technology. Founded in 1958, the company has carved out a niche in the development and provision of analytical instruments and software solutions. The backbone of its operations is liquid chromatography, mass spectrometry, and thermal analysis technologies. These tools are indispensable to laboratories in various sectors, including pharmaceuticals, biotechnology, food, and environmental testing. By providing cutting-edge technology to these industries, Waters Corp. ensures precise and accurate data, fundamental for research, quality control, and regulatory compliance. Each instrument is designed to address specific analytical challenges—be it the quantification of drug compounds or the detection of contaminants—thereby empowering scientists to achieve breakthroughs and maintain rigorous standards. The financial engine driving Waters Corp. revolves around the continual demand for its high-value instruments and the recurring revenue spurred by its after-market services and consumables. Beyond the sale of its sophisticated tools, the company nurtures long-term relationships with its clients through its service offerings, which include maintenance, training, and consultation. Furthermore, consumables associated with their instruments ensure a steady stream of income; these are indispensable for daily laboratory operations. By leveraging its reputation for reliability and innovation, Waters Corp. not only fosters customer loyalty but also sustains a profitable business model, adeptly navigating the evolving landscapes of science and technology.
See Also
What is Waters Corp's EPS (Diluted)?
EPS (Diluted)
10.8
USD
Based on the financial report for Dec 31, 2025, Waters Corp's EPS (Diluted) amounts to 10.8 USD.
What is Waters Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
7%
Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for Waters Corp have been -3% over the past three years , 5% over the past five years , and 7% over the past ten years .